期刊文献+

磷脂酶A_2抑制剂对卵巢癌细胞转移潜能的影响 被引量:1

Effect of inhibitors of phospholipase A_2 on the metastasis potentials of human ovarian cancer cells
下载PDF
导出
摘要 目的:卵巢癌细胞可分泌大量溶血性磷脂酸(LPA),LPA促进卵巢癌的发展,磷脂酶A2是LPA合成的主要酶。拟研究磷脂酶A2的抑制剂能否抑制卵巢癌的转移。方法:Transwell检测细胞迁移能力变化;Western blot检测磷脂酶A2的表达/活化状态;ECIS检测细胞浸润能力;质谱分析LPA浓度;裸鼠卵巢癌模型检测肿瘤的转移。结果:在体外LPA以剂量依赖方式促进SKOV3细胞的迁移和黏附;SK-OV3细胞内具有高表达和活化的iPLA2和cPLA2酶;应用AACOCF3和HELSS后,SKOV3分泌的LPA显著减少;AA-COCF3和HELSS显著抑制裸鼠内SKOV3的远地转移。结论:LPA显著促进SKOV3的迁移、黏附、对单层腹膜的浸润。AACOCF3和HELSS显著抑制SKOV3分泌LPA、并显著抑制SKOV3的迁移和浸润,还抑制裸鼠内SKOV3的远地转移,AACOCF3和HELSS有可能成为卵巢癌转移的潜在抑制剂。 AIM:It is important to find inhibitors for metastasis of ovarian cancer (OC).OC cells (OCC) produce Lysophosphophatidic acid (LPA),which promotes the OC development.Phospholipase A2 (PLA2) is responsible for LPA production.This study is to investigate the effect of PLA2 inhibitors on the metastasis of OC.METHODS:Cell migration and adhesion were measured by Transwell assay.The expression and activation of PLA2 were detected by Western blot.Invasion into the peritoneal monolayer was detected through ECIS.LPA concentration was measured by mass spectrum.Metastasis was detected through in vivo OC model.RESULTS:(1) LPA promoted the migration and adhesion of SKOV3 in a dose-dependent manner in vitro;(2) iPLA2 and cPLA2 expressed highly and activated in SKOV3.(3)AACOCF3 and HELSS significantly inhibited LPA secretion from SKOV3;(4)AACOCF3 and HELSS significantly inhibited the distant metastasis of SKOV3 in mude mice model.CONCLUSION:LPA significantly enhanced the migration,adhesion and invasion of SKOV3.AACOCF3 and HELSS significantly inhibited the LPA secretion,migration and invasion of SKOV3.They also inhibited the distant metastasis of SKOV3 in vivo.Our data suggest AACOCF3 and HELSS may be the potential inhibitors of metastasis of OC.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第10期992-995,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 陕西省科技计划项目基金(2007K09-09) 国家自然科学基金资助项目(30973175) 教育部留学归国人员科研启动基金 西安交通大学第一附属医院临床科研基金资助(2009年)
关键词 卵巢肿瘤 肿瘤转移 溶血性磷脂酸 细胞内磷脂酶A2 ovarian cancer tumor metastasis lysophosphophatidic acid(LPA) phospholipase A2
  • 相关文献

参考文献8

  • 1Xu Y, Gaudette DC, Bpynton JD, et al. Characterization of an ovarian cancer activating in ascites from ovarian cancer patients[ J]. J Clin Cancer Res, 1995, 1(10) : 1223 -1232.
  • 2Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [ J ]. J Am Med Assoc, 1998, 280(8): 719-723.
  • 3Zaslavsky A, Singh LS, Tan H, et al. Homo-and hetero-dimerization of LPA/SIP receptors, OGR1 and GPR4 [ J ]. Bioehim Biophys Acta, 2006, 1761 (10) : 1200 - 1212.
  • 4Sutphen R, Xu Y, Wilbanks GD, et al. Lysophospholipids are potential biomarkers of ovarian cancer [ J ]. Cancer Epidemiol Biomarkers Prey, 2004, 13(7): 1185-1191.
  • 5Zhao XX, Wang DM, Zhao ZW, et al. Caspase-3 dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells [ J]. J Biol Chem, 2006, 281 ( 39 ) : 29357 - 29368.
  • 6Ren J, Xiao YJ, Singh SL, et al. LPA is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration and invasion of ovarian cancer cells[J]. Cancer Res, 2006, 66(6) : 3006 - 3014.
  • 7Park G, Choi CK, English AE, et al. Electrical impedance measurements predict cellular transformation [ J ]. Cell Biol Int, 2009, 33 (3) : 429 -433.
  • 8Xiao YJ, Schwartz B, Washington M, et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids[J]. Anal Biochem, 2001,290(2) : 302 -313.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部